...Spigarelli as CMO. Spigarelli was VP, medical affairs for Immucor Inc. (see “Lumen $16M Series B”). Sensyne Health plc...

...the company plans to build the database out to 5 million patients. Under the deal, Sensyne Health plc...
...out AI and digital health-focused companies from the University of Oxford. Elizabeth S. Eaton, Staff Writer Bayer AG Sensyne Health plc...

...Gains Zejula" ). Sensyne, Evotec partner to spin out AI research at Oxford AI company Sensyne Health plc...
...Other) Zejula (Brand), ZL-2306 (Compound #), MK-4827 (Compound #), niraparib (Generic), Zejula (Informal) AbbVie Inc. Evotec AG Genfit S.A. GlaxoSmithKline plc Sensyne Health plc Terns...

...patients. Bayer, Sensyne Health partner to analyze patient data Bayer AG (Xetra:BAYN) will collaborate with Sensyne Health plc...
...AG EirGenix Inc. G1 Therapeutics Inc. Johnson & Johnson Luye Pharma Group Ltd. Merck & Co. Inc. Novan Inc. Novartis AG Pfizer Inc. PharmaMar S.A. Sandoz Sensyne Health plc Vertex...

...Jan. 27, the day before the deal was announced. Wye is eligible for shared royalties. Sensyne Health plc...
...Oxford, U.K. University of Oxford, Oxford, U.K. Wye Valley NHS Trust, Hereford, U.K. Business: Renal/Cardiovascular Shannon Lehnbeuter Sensyne Health plc University...

...A) 8/21/18 $23.7 NA $52.6 NA Biosolution Co. Ltd. (KOSDAQ:086820) 8/20/18 $38.8 $198.0 $222.1 12% Sensyne Health plc...

...Data analysis company Sensyne Health plc (Oxford, U.K.) proposed to raise £60 million ($78 million) in an IPO...
...the University of Oxford. In 1993, Bell founded the Wellcome Trust Centre for Human Genetics. Sensyne Health plc...

...Data analysis company Sensyne Health plc (Oxford, U.K.) proposed to raise £60 million ($78 million) in an IPO...